Dolutegravir 50 mg
Dolutegravir 50 mg Tablets are an integrase strand transfer inhibitor (INSTI) recognized for their high genetic barrier to resistance and are widely used as a cornerstone of modern antiretroviral therapy for the treatment of HIV-1 infection, in line with current treatment recommendations.
Product Details
Therapeutic Class
HIV Integrase Strand Transfer Inhibitor (INSTI)
Indication
Treatment of HIV-1 infection in adults and adolescents as part of combination antiretroviral therapy (ART), in accordance with WHO and NACO recommendations.
Dosage & Administration
50 mg once daily or twice daily depending on the treatment regimen and patient profile, or as prescribed by a healthcare professional.
To be used strictly as part of a combination ART regimen.
Storage
Store below 30°C in a dry place, protected from light and moisture.
Disclaimer
Prescription medicine. To be used only under medical supervision and in line with WHO and NACO treatment guidelines.
*This combination is under patent protection in several markets. Supply, manufacture, or distribution is subject to applicable patent laws and local regulatory approvals.
Pack Size
30 tablets
Dolutegravir 50 mg
Dolutegravir 50 mg Tablets are an integrase strand transfer inhibitor (INSTI) recognized for their high genetic barrier to resistance and are widely used as a cornerstone of modern antiretroviral therapy for the treatment of HIV-1 infection, in line with current treatment recommendations.
Product Details
Therapeutic Class
HIV Integrase Strand Transfer Inhibitor (INSTI)
Indication
Treatment of HIV-1 infection in adults and adolescents as part of combination antiretroviral therapy (ART), in accordance with WHO and NACO recommendations.
Dosage & Administration
50 mg once daily or twice daily depending on the treatment regimen and patient profile, or as prescribed by a healthcare professional.
To be used strictly as part of a combination ART regimen.
Storage
Store below 30°C in a dry place, protected from light and moisture.
Disclaimer
Prescription medicine. To be used only under medical supervision and in line with WHO and NACO treatment guidelines.
*This combination is under patent protection in several markets. Supply, manufacture, or distribution is subject to applicable patent laws and local regulatory approvals.
Pack Size
30 tablets
Dolutegravir 50 mg
Dolutegravir 50 mg Tablets are an integrase strand transfer inhibitor (INSTI) recognized for their high genetic barrier to resistance and are widely used as a cornerstone of modern antiretroviral therapy for the treatment of HIV-1 infection, in line with current treatment recommendations.
Product Details
Therapeutic Class
HIV Integrase Strand Transfer Inhibitor (INSTI)
Indication
Treatment of HIV-1 infection in adults and adolescents as part of combination antiretroviral therapy (ART), in accordance with WHO and NACO recommendations.
Dosage & Administration
50 mg once daily or twice daily depending on the treatment regimen and patient profile, or as prescribed by a healthcare professional.
To be used strictly as part of a combination ART regimen.
Storage
Store below 30°C in a dry place, protected from light and moisture.
Disclaimer
Prescription medicine. To be used only under medical supervision and in line with WHO and NACO treatment guidelines.
*This combination is under patent protection in several markets. Supply, manufacture, or distribution is subject to applicable patent laws and local regulatory approvals.
Pack Size
30 tablets